Aspiriant, LLC Illumina, Inc. Transaction History

Aspiriant, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	BUY	$181.58 - $368.0 $4,176 - $8,464	23 Added 2.05%	1,146 $211,000
Q1 2022 May 06, 2022	SELL	$303.87 - $423.8 $4,254 - $5,933	-14 Reduced 1.23%	1,123 $392,000
Q4 2021 Feb 14, 2022	BUY	$347.28 - $421.83 $3,820 - $4,640	11 Added 0.98%	1,137 $433,000
Q2 2021 Aug 13, 2021	BUY	$372.84 - $481.5 $419,817 - $542,169	1,126 New	1,126 $532,000
Q3 2020 Oct 29, 2020	SELL	$268.51 - $400.74 $466,938 - $696,886	-1,739 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$266.84 - $378.23 $14,676 - $20,802	55 Added 3.27%	1,739 $529,000
Q2 2019 Aug 06, 2019	BUY	$300.59 - $368.15 $30,660 - $37,551	102 Added 6.45%	1,684 $620,000
Q1 2019 May 03, 2019	SELL	$272.57 - $321.18 $100,578 - $118,515	-369 Reduced 18.91%	1,582 $492,000
Q4 2018 Feb 04, 2019	SELL	$272.46 - $366.54 $77,923 - $104,830	-286 Reduced 12.78%	1,951 $585,000
Q3 2018 Oct 26, 2018	SELL	$279.04 - $367.06 $27,066 - $35,604	-97 Reduced 4.16%	2,237 $820,000
Q2 2018 Aug 07, 2018	BUY	$228.17 - $292.07 $8,898 - $11,390	39 Added 1.7%	2,334 $652,000
Q1 2018 May 04, 2018	BUY	$209.54 - $253.91 $480,894 - $582,723	2,295 New	2,295 $543,000
Q4 2017 Jan 31, 2018	SELL	$202.23 - $230.03 $474,633 - $539,880	-2,347 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$172.3 - $213.93 $404,388 - $502,093	2,347	2,347 $468,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspiriant, LLC with notifications on news.